ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
T

EHA 2021 Update on D-Rd vs. Rd in Transplant-Ineligible Newly Diagnosed MM: MAIA Study

By ecancer FEATURING Thierry Facon
By ecancer FEATURING Thierry Facon
19 views
September 2, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Myeloma
08:50

New

Isa-KRd in NDMM: Takeaways From the MIDAS & CONCEPT Studies

ecancer

P. Moreau

9 views
06:02

New

Frailty Subanalysis of IMROZ: Isatuximab + RVD for Transplant-Inelig…

ecancer

S. Manier

10 views
06:12

Idecabtagene Vicleucel for R/R MM: Updated Results From the KarMMa T…

ecancer

L. Anderson

60 views
07:41

Efficacy and Safety Data for Ciltacabtagene Autoleucel in Progressiv…

ecancer

A. Cohen

126 views
05:51

Melflufen and Dexamethasone vs. Pomalidomide and Dexamethasone in R/…

ecancer

F. Schjesvold

50 views
06:50

EHA 2021 Highlights on KRd for Lenalidomide-Refractory MM

ecancer

C. Cerchione

92 views
07:49

EHA 2021 Update on Carfilzomib Non-refractory MM: Surveying Efficacy…

ecancer

C. Gasparetto

66 views
05:49

EHA 2021 Update on D-Rd vs. Rd in Transplant-Ineligible Newly Diagno…

ecancer

T. Facon

19 views
28:47

ASH Updates on IO in R/R MM: Which Agents Are Available and How to C…

ecancer

R. Rifkin, S. Lonial, E. Smith, E. Terpos, N. Shah

122 views
06:59

ESMO Guidelines on Bone Health in Cancer: What Is the Agent of Choic…

ecancer

R. Coleman

11 views
20:31

ASH 2020 MM Expert Discussion: What Does IKEMA, ICARIA-MM & APOLLO D…

ecancer

M. Mateos, M. Dimopolous, S. Kumar, M. Beksaç

367 views